Efficacy and Safety of the Glucagon Receptor Antagonist RVT-1502 in Type 2 Diabetes Uncontrolled on Metformin Monotherapy: A 12-Week Dose-Ranging Study. [electronic resource]
Producer: 20200914Description: 161-168 p. digitalISSN:- 1935-5548
- Adult
- Aged
- Alkanesulfonates -- administration & dosage
- Benzamides -- administration & dosage
- Blood Glucose -- drug effects
- Diabetes Mellitus, Type 2 -- drug therapy
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Resistance -- drug effects
- Drug Therapy, Combination
- Female
- Humans
- Hypoglycemic Agents -- administration & dosage
- Male
- Metformin -- therapeutic use
- Middle Aged
- Receptors, Glucagon -- antagonists & inhibitors
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.